
TheB133.5monoclonalantibodyreactswithhumanIFNγ(interferongamma)a20kDasolublepleiotropiccytokineandthesolememberofthetypeIIclassofinterferons.IFNγisprimarilyproducedbyactivatedlymphocytesincludingT,B,NKcells,andILCs.IFNγexertsimmunoregulatory,anti-proliferative,anti-viral,andproinflammatoryactivitiesandplaysanimportantroleinactivation,growth,anddifferentiationofTandBlymphocytes,macrophages,NKcellsandothernon-hematopoieticcelltypes.Additionally,IFNγinducestheproductionofcytokines,Fcreceptor,andadhesionmoleculesandup-regulatesMHCclassIandIIantigenexpressionbyantigenpresentingcellsduringanimmuneresponse.IFNγhasalsobeenshowntomodulatemacrophageeffectorfunctions,influenceisotypeswitchingandinducethesecretionofimmunoglobulinsbyBcells.IFNγsignalsthroughtheIFNgammareceptorwhichexistsasaheterodimercomposedofCD119(IFNgammareceptor1)andAF-1(IFNgammareceptor2).TheIFNγreceptorisexpressedubiquitouslyonalmostallcelltypeswiththeexceptionofmatureerythrocytes.TheB133.5antibodyisaneutralizingantibody.
Isotype | MouseIgG1 |
RecomendedIsotypeControl(s) | InVivoMAbmouseIgG1isotypecontrol,unknownspecificity |
RecommendedInVivoPureDilutionBuffer | InVivoPurepH7.0DilutionBuffer |
Immunogen | RecombinanthumanIFNγ |
ReportedApplications | invitroIFNγneutralization |
Endotoxin |
|
Purity |
|
Formulation |
|
Sterility | 0.2μMfiltered |
Production | Purifiedfromtissueculturesupernatantinananimalfreefacility |
Purification | ProteinG |
Storage | Undilutedat4°Cinthedark |